Use clinical judgement to create a pharmaceutical treatment regime
Read the required reading and respond:
Use clinical judgement to create a pharmaceutical treatment regimen for each of the following. The details are your own to assume that may impact your choices beyond the information provided.
- 2 y/o with decreased serum iron, decreased iron stores, with increased total iron-binding capacity (TIBC), increased transferrin levels, fully weaned from formula 3 months ago. DX IDA
- 45 y/o with RBC count normal/high, low MCV, target cells, and basophilic stippling are on peripheral smear. Mediterranean descent. DX Thallisemia
- 78 y/o with MCV>100, RBCs 1.20, HGB 8.0, an elevated methylmalonic and homocysteine level of 79, Vit b12 <50 with new peripheral neuropathies. DX Pernicious Anemia
- Utilize clinical practice guidelines to begin drug therapy following evidence based practice. The prescription details must be present and any non-prescriptions.
- For each: the drug name, dose, route, frequency of administration and if prescribed, the quantity to dispense must be present.
- Include the drug class details
- The duration of the therapy must be included.
- Include other considerations in their treatment plan as applicable.
- Therapeutic monitoring should be included, labs and responses
- Justify your decision.
- Finally address equity and inclusion factors to consider with anemias.
Provide 3 evidence based references for your stance using standard APA 7 format.

Leave a Reply
You must be logged in to post a comment.